Previous 10 | Next 10 |
Summary Jeff Smith’s 13F portfolio value decreased from $7.54B to $5.50B this quarter. Starboard Value increased NortonLifeLock and Mercury Systems while decreasing ON Semiconductor, Huntsman Corp, Corteva, Enovis, and Kohl’s. The largest three individual stock p...
Summary As the era of free money comes to an end, the gene testing industry is faced with the challenge of transforming itself into a commercially viable sector. Though it is still early days for the industry, major players have embarked on restructuring efforts to transform thems...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Divi...
From Cano Health ( CANO ) to One Medical ( ONEM ), the companies exposed to value-based care (VBC) are on a roll amid rising buyout interest as the industry heavyweights look to benefit from a lucrative alternative to a traditional reimbursement model. VBC ties reimbursement...
Summary DPNCheck is a screening product sold to MA insurers which gives better member health outcomes, lower cost, and increased revenue for MA insurers. The product has consistently grown >20%. Discontinuation of Quell marketing in 2018 is masking the strong, underlying growth...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: metamorworks / Shutterstock Cano Health (NYSE: CANO ) stock is moving on Friday from reports that Humana (NYSE: HUM ) and CVS (NYSE: CVS ) are considering buying the company . According to...
Blue chip stocks are highly valued shares of large, well-established, and financially sound companies. They are called blue chips because they are considered some of the safest and most reliable investments in the stock market . Blue chip stocks tend to be less volatile than other s...
Morgan Stanley has upgraded Humana to overweight from equal weight citing the managed care provider's expected strong Medicare Advantage growth in 2023. The firm has a $549 price target (~10% upside based on Monday's close). Analyst Michael Ha said that Humana ( NYSE: HUM ...
Shares of Humana Inc. (NYSE: HUM) traded at a new 52-week high today and are currently trading at $509.08. So far today, approximately 766.54k shares have been exchanged, as compared to an average 30-day volume of 802.91k shares. Humana Inc., together with its subsidiaries, operates as a...
The shares of Humana Inc. ( NYSE: HUM ) jumped ~9% Thursday, recording the best intraday gain since April 2020 after the company raised its full-year 2022 outlook and set its 2025 adj. earnings per share guidance ahead of the consensus. In terms of adj. earnings pe...
News, Short Squeeze, Breakout and More Instantly...
New collaboration will allow Humana to further modernize its cloud infrastructure and leverage Google Cloud’s Generative AI capabilities to accelerate innovation in healthcare. Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced a new multi-year agre...
Key investments with community partners expand options for historically unsupported populations Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana Inc. (NYSE: HUM), is investing in community-based organizations throughout Oklahoma to expan...
Lease agreement for new CenterWell Senior Primary Care and Conviva Care Centers locations will provide convenient primary care services designed especially for seniors. CenterWell, the health care services business of Humana Inc. (NYSE: HUM), today announced plans to lease clinical spac...